Peggy A. Bulur

Mayo Clinic — United States

Immunology and Microbiology · Life Sciences

14h-index1.7kcitations59works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(30), Immune cells in cancer(25), Cancer Immunotherapy and Biomarkers(22), Immune Cell Function and Interaction(18), CAR-T cell therapy research(9)

Publications59 total

Bioreactor on a chip: a microfluidic device for closed production of human dendritic cells
Cytotherapy·2024· 1 citedOpen Access
Supplemental Table 1 from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Supplemental Table 2 from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Legend for Supplemental Figure 2legend from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Supplemental Table 2 from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Supplemental Figure 1 from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Data from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Supplemental Figure 3 from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Supplemental Figure 2 from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Supplemental Figure 2 from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Supplemental Figure 1 from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Supplemental Figure 3 from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Supplemental Figure 4 from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Legend for Supplemental Figure 2legend from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Supplemental Table 1 from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Data from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Supplemental Figure 4 from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Tumor Microenvironment CD14+ Cells Correlate with Poor Overall Survival in Patients with Early-Stage Lung Adenocarcinoma
Cancers·2022· 9 citedOpen Access
CD36 Identifies a Subpopulation of Adipose-Derived Mesenchymal Stromal Cells with Enhanced Osteogenic Ability.
2021Open Access
Plasticity – The Double-Edged Sword Wielded by MSCs that Impacts Cellular Phenotype
Cytotherapy·2020
page 1 of 3Next →

Frequent Co-authors

Allan B. Dietz(50), Michael P. Gustafson(27), Yi Lin(23), Susan M. Harrington(15), Eugene D. Kwon(15), Rebecca R. Laborde(15), Dennis A. Gastineau(14), Jonathan Bleeker(14), Deepti Warad(14), Matthew K. Tollefson(14), Paul L. Crispen(14), Bradley C. Leibovich(14), John C. Cheville(14), Stanimir Vuk‐Pavlović(12), Dennis A. Gastineau(12), Thomas E. Witzig(7), Greg W. Butler(7), Mary Maas(6), Mark R. Litzow(5), Svetomir N. Markovic(5)